The FY2025 (Dec) proxy of Dyne Therapeutics names 18 peer companies for pay. Pay versus performance data of Dyne Therapeutics for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| BridgeBio Pharma | ||
| Revolution Medicines | ||
| Cytokinetics | ||
| Immunovant | ||
| IDEAYA Biosciences | ||
| Xenon Pharmaceuticals | ||
| Kymera Therapeutics | ||
| CRISPR Therapeutics AG | ||
| Arvinas | ||
| Beam Therapeutics | ||
| Celldex Therapeutics | ||
| Intellia Therapeutics | ||
| Denali Therapeutics | ||
| Keros Therapeutics | ||
| Arcellx | Not disclosed | Not disclosed |
| Crinetics Pharmaceuticals | Not disclosed | Not disclosed |
| Nuvalent | Not disclosed | Not disclosed |
| Rocket Pharmaceuticals | Not disclosed | Not disclosed |
18 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.